TipRanks
Go Ultimate55% OFF

Manzo Pharmaceuticals (MNZO) Financial Statements

Manzo Pharmaceuticals Financial Overview

Manzo Pharmaceuticals's market cap is currently $5.00K. The company's EPS TTM is ―; its P/E ratio is -9.83; Manzo Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 04Dec 03
Income Statement
Total Revenue――
Gross Profit$ 20.97K$ 755.89K
Operating Income$ -3.20M$ -3.25M
EBITDA$ -2.85M$ -2.30M
Net Income$ -4.15M$ -3.95M
Balance Sheet
Cash & Short-Term Investments――
Total Assets$ 1.29M$ 4.99M
Total Debt$ 6.52M$ 7.31M
Net Debt$ 6.51M$ 7.30M
Total Liabilities$ 23.79M$ 23.46M
Stockholders' Equity――
Cash Flow
Free Cash Flow$ -1.11M$ -1.59M
Operating Cash Flow――
Investing Cash Flow――
Financing Cash Flow――

Currency in USD